Metformin, primarily used as a diabetes medication, has been found to potentially aid in colon cancer prevention, as reflected in lower rates among users. Recent research, presented at a cancer conference in Chicago, explores its ability to combat colon cancer cells directly, particularly those with challenging KRAS mutations. While still in the early stages, initial findings suggest metformin could be an adjunct therapy alongside conventional cancer treatments, although it isn't suitable as a standalone treatment. Further studies in animals and humans are needed for clinical application.
"Metformin seems like it could have a really interesting supplemental approach to therapy... We're opening up some doors to what this could do."
"Previous research has highlighted how people taking metformin for diabetes have lower colon cancer rates, suggesting the drug may be doing something protective to help prevent cancer from developing."
Collection
[
|
...
]